Arcutis Biotherapeutics Stock Analysis

Arcutis Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.04. Arcutis Biotherapeutics had not issued any dividends in recent years. Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. Arcutis Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 147 people. For more info on Arcutis Biotherapeutics please contact Todd MA at 805 418 5006 or go to https://www.arcutis.com.

Arcutis Biotherapeutics Investment Alerts

Arcutis Biotherapeutics Upcoming and Recent Events

Arcutis Largest EPS Surprises

View All Earnings Estimates

Arcutis Biotherapeutics Environmental, Social, and Governance (ESG) Scores

Arcutis Stock Institutional Investors

Note, although Arcutis Biotherapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arcutis Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.73 B.

Arcutis Profitablity

The company has Profit Margin (PM) of (0.61) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.37.

Management Efficiency

Arcutis Biotherapeutics has return on total asset (ROA) of (0.1843) % which means that it has lost $0.1843 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7058) %, meaning that it created substantial loss on money invested by shareholders. Arcutis Biotherapeutics' management efficiency ratios could be used to measure how well Arcutis Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.43 in 2025. Return On Capital Employed is likely to drop to -0.5 in 2025. At this time, Arcutis Biotherapeutics' Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 116.6 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 276.1 M in 2025.

Technical Drivers

As of the 23rd of July, Arcutis Biotherapeutics shows the mean deviation of 2.32, and Risk Adjusted Performance of 0.073. Arcutis Biotherapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Arcutis Biotherapeutics Price Movement Analysis

Arcutis Biotherapeutics Insider Trading Activities

Arcutis Biotherapeutics Outstanding Bonds

Arcutis Biotherapeutics Predictive Daily Indicators

Arcutis Biotherapeutics Corporate Filings

Arcutis Biotherapeutics Forecast Models

Arcutis Biotherapeutics' time-series forecasting models are one of many Arcutis Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arcutis Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arcutis Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arcutis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arcutis Biotherapeutics. By using and applying Arcutis Stock analysis, traders can create a robust methodology for identifying Arcutis entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arcutis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arcutis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Arcutis Biotherapeutics stock analysis indicators help investors evaluate how Arcutis Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arcutis Biotherapeutics shares will generate the highest return on investment. By understating and applying Arcutis Biotherapeutics stock analysis, traders can identify Arcutis Biotherapeutics position entry and exit signals to maximize returns.

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.